{"id":2504,"date":"2023-09-05T09:00:00","date_gmt":"2023-09-05T07:00:00","guid":{"rendered":"http:\/\/localhost:8888\/disputa-legal-las-sociedades-idime-dime-clinica-neurocardiovascular\/"},"modified":"2023-09-05T09:00:00","modified_gmt":"2023-09-05T07:00:00","slug":"disputa-legal-las-sociedades-idime-dime-clinica-neurocardiovascular","status":"publish","type":"post","link":"https:\/\/cloudactive.net\/vera\/disputa-legal-las-sociedades-idime-dime-clinica-neurocardiovascular\/","title":{"rendered":"Disputa legal entre las sociedades IDIME y DIME Cl\u00ednica Neurocardiovascular"},"content":{"rendered":"<p><\/p>\n<p style=\"text-align: justify;\">La SIC resuelve la demanda de IDIME contra la Superintendencia de Industria y Comercio (SIC) por el registro de la marca DIME concedido a Dime Cl\u00ednica Neurocardiovascular. IDIME objet\u00f3 la solicitud de Dime Cl\u00ednica Neurocardiovascular, bas\u00e1ndose en su nombre comercial IDIME. La SIC inicialmente acept\u00f3 la objeci\u00f3n pero, tras apelaci\u00f3n, revoc\u00f3 su decisi\u00f3n y concedi\u00f3 el registro. IDIME alega vulneraci\u00f3n de normativas internacionales por similitud entre DIME y IDIME. Aunque la marca DIME otorgada a Dime Cl\u00ednica Neurocardiovascular fue cancelada por no uso, la Sala concluye que la causal de nulidad invocada ya no es aplicable. La Sala pone fin al proceso, permitiendo el registro de la marca DIME a Dime Cl\u00ednica Neurocardiovascular.<\/p>\n<p><a href=\"https:\/\/cloudactive.net\/vera\/wp-content\/uploads\/2023\/09\/31083625.pdf\" target=\"_blank\" rel=\"noopener\">Ver sentencia<\/a><br \/>\n<span style=\"font-size: 8pt;\"><em>Notinet<\/em><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>La SIC resuelve la demanda de IDIME contra la Superintendencia de Industria y Comercio (SIC) por el registro de la marca DIME concedido a Dime Cl\u00ednica Neurocardiovascular. IDIME objet\u00f3 la solicitud de Dime Cl\u00ednica Neurocardiovascular, bas\u00e1ndose en su nombre comercial IDIME. La SIC inicialmente acept\u00f3 la objeci\u00f3n pero, tras apelaci\u00f3n, revoc\u00f3 su decisi\u00f3n y concedi\u00f3 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2458,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-2504","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"_links":{"self":[{"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/posts\/2504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/comments?post=2504"}],"version-history":[{"count":0,"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/posts\/2504\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/media\/2458"}],"wp:attachment":[{"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/media?parent=2504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/categories?post=2504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cloudactive.net\/vera\/wp-json\/wp\/v2\/tags?post=2504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}